February 1, 2026 · Form 4 insider transaction
Levy Richard S bought 683 shares of Kiniksa Pharmaceuticals Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.; The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.